Price movement over the last 24 hours
Agilent Technologies Inc vs Kraft Heinz Co — how do they compare? Agilent Technologies Inc trades at $128.33 (market cap $37.04B), while Kraft Heinz Co trades at $25.01 (market cap $30.00B). The key difference: Agilent Technologies Inc is the larger of the two by market cap, and Kraft Heinz Co pays the higher dividend (6.32%). Which is the better fit depends on your goals.
| A | KHC | |
|---|---|---|
Market Cap | $37.04B | $30.00B |
Sector | Health | Consumer Staples |
52-Week High | $157.20 | $28.94 |
52-Week Low | $110.24 | $21.21 |
Enterprise Value | $38.59B | $47.04B |
Dividend Yield | 0.78% | 6.32% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Kraft Heinz (KHC) trades at $25.3, down 0.28% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The company reported a net loss of $5.85 billion in 2025, driving negative profit margins, but maintains strong operating cash flow of $4.46 billion and a 6.4% dividend yield. Recent news highlights a global reorganization aimed at accelerating growth and a strategic partnership with Heineken.
KHC presents a mixed outlook: attractive valuation metrics (P/E 13.04, P/B 0.7) and bullish technicals support potential upside, but significant profitability challenges and a cautious analyst consensus (57% hold rating) indicate headwinds. Key risks include execution of the new operating structure and sustained negative earnings, while the high dividend yield offers income appeal.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →